loadpatents
Patent applications and USPTO patent grants for Koike; Tatsuki.The latest application filed is for "heterocyclic compound".
Patent | Date |
---|---|
Heterocyclic compound and use thereof Grant 11,440,883 - Kajita , et al. September 13, 2 | 2022-09-13 |
Heterocyclic compound and application thereof Grant 11,319,286 - Fujimoto , et al. May 3, 2 | 2022-05-03 |
Heterocyclic Compound App 20220017514 - KAJITA; Yuichi ;   et al. | 2022-01-20 |
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases Grant 11,174,272 - Koike , et al. November 16, 2 | 2021-11-16 |
Heterocyclic Compound And Use Thereof App 20210276949 - HATTORI; Yasushi ;   et al. | 2021-09-09 |
Heterocyclic Compound And Application Thereof App 20210269420 - FUJIMOTO; Tatsuhiko ;   et al. | 2021-09-02 |
Substituted pyrrolidine compound and use thereof Grant 11,059,780 - Daini , et al. July 13, 2 | 2021-07-13 |
1-arylcarbonyl-4-oxy-piperidine Compounds Useful For The Treatment Of Neurodegenerative Diseases App 20210206781 - KOIKE; Tatsuki ;   et al. | 2021-07-08 |
Heterocyclic Compound And Use Thereof App 20210198240 - ODA; Tsuneo ;   et al. | 2021-07-01 |
Substituted pyrrolidine compound and use thereof Grant 11,034,700 - Mikami , et al. June 15, 2 | 2021-06-15 |
Heterocyclic compound and use thereof Grant 11,028,048 - Hattori , et al. June 8, 2 | 2021-06-08 |
Substituted Pyrrolidine Compound And Use Thereof App 20200392149 - MIKAMI; Satoshi ;   et al. | 2020-12-17 |
Document Creation Assistance Server And Document Creation Assistance Method App 20200388354 - NARA; Hiroshi ;   et al. | 2020-12-10 |
Substituted Pyrrolidine Compound And Use Thereof App 20200385345 - DAINI; Masaki ;   et al. | 2020-12-10 |
Heterocyclic Compound And Application Thereof App 20200385346 - FUJIMOTO; Tatsuhiko ;   et al. | 2020-12-10 |
Heterocyclic Compound And Use Thereof App 20200247747 - Kind Code | 2020-08-06 |
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases Grant 10,717,748 - Koike , et al. | 2020-07-21 |
Heterocyclic Compound And Use Thereof App 20200207715 - Kajita; Yuichi ;   et al. | 2020-07-02 |
Heterocyclic Compound And Use Thereof App 20200207734 - KAJITA; Yuichi ;   et al. | 2020-07-02 |
1-arylcarbonyl-4-oxy-piperidine Compounds Useful For The Treatment Of Neurodegenerative Diseases App 20200157117 - KOIKE; Tatsuki ;   et al. | 2020-05-21 |
Heterocyclic compound and use thereof Grant 10,584,097 - Kajita , et al. | 2020-03-10 |
Aromatic ring compound Grant 10,548,877 - Ogino , et al. Fe | 2020-02-04 |
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases Grant 10,550,129 - Koike , et al. Fe | 2020-02-04 |
Heterocyclic Compound And Use Thereof App 20200017444 - KAJITA; Yuichi ;   et al. | 2020-01-16 |
Heterocyclic compound and use thereof Grant 10,428,023 - Kajita , et al. October 1, 2 | 2019-10-01 |
1-arylcarbonyl-4-oxy-piperidine Compounds Useful For The Treatment Of Neurodegenerative Diseases App 20190233436 - KOIKE; Tatsuki ;   et al. | 2019-08-01 |
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases Grant 10,273,245 - Koike , et al. | 2019-04-30 |
Aromatic Ring Compound App 20190083467 - OGINO; Masaki ;   et al. | 2019-03-21 |
1-arylcarbonyl-4-oxy-piperidine Compounds Useful For The Treatment Of Neurodegenerative Diseases App 20190071455 - KOIKE; Tatsuki ;   et al. | 2019-03-07 |
Heterocyclic compound Grant 10,202,376 - Kimura , et al. Feb | 2019-02-12 |
Heterocyclic Compound And Use Thereof App 20190040010 - Kajita; Yuichi ;   et al. | 2019-02-07 |
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases Grant 10,144,743 - Koike , et al. De | 2018-12-04 |
Heterocyclic compounds having cholesterol 24-hydroxylase activity Grant 10,112,956 - Koike , et al. October 30, 2 | 2018-10-30 |
Heterocyclic compound Grant 10,106,556 - Ikeda , et al. October 23, 2 | 2018-10-23 |
Radiolabeled compounds Grant 9,963,443 - Koike , et al. May 8, 2 | 2018-05-08 |
Heterocyclic Compound App 20180079756 - IKEDA; Shuhei ;   et al. | 2018-03-22 |
Heterocyclic Compound App 20170362223 - KIMURA; Eiji ;   et al. | 2017-12-21 |
Heterocyclic Compounds Having Cholesterol 24-hydroxylase Activity App 20170197983 - KOIKE; Tatsuki ;   et al. | 2017-07-13 |
1-arylcarbonyl-4-oxy-piperidine Compounds Useful For The Treatment Of Neurodegenerative Diseases App 20170145031 - KOIKE; Tatsuki ;   et al. | 2017-05-25 |
Heterocyclic compounds having cholesterol 24-hydroxylase activity Grant 9,643,957 - Koike , et al. May 9, 2 | 2017-05-09 |
Radiolabeled Compounds App 20170114042 - KOIKE; Tatsuki ;   et al. | 2017-04-27 |
4-(piperrazin-1-yl)-pyrrolidin-2-one compounds as monoacylglycerol lipase (MAGL) inhibitors Grant 9,624,170 - Koike , et al. April 18, 2 | 2017-04-18 |
Heterocyclic compound Grant 9,624,184 - Koike , et al. April 18, 2 | 2017-04-18 |
Heterocyclic compound Grant 9,598,398 - Koike , et al. March 21, 2 | 2017-03-21 |
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases Grant 9,586,930 - Koike , et al. March 7, 2 | 2017-03-07 |
1-arylcarbonyl-4-oxy-piperidine Compounds Useful For The Treatment Of Neurodegenerative Diseases App 20160326136 - KOIKE; Tatsuki ;   et al. | 2016-11-10 |
4-(piperrazin-1-yl)-pyrrolidin-2-one Compounds As Monoacylglycerol Lipase (magl) Inhibitors App 20160318864 - KOIKE; Tatsuki ;   et al. | 2016-11-03 |
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases Grant 9,440,990 - Koike , et al. September 13, 2 | 2016-09-13 |
Heterocyclic compound Grant 9,296,746 - Koike , et al. March 29, 2 | 2016-03-29 |
Heterocyclic Compound App 20160052897 - KOIKE; Tatsuki ;   et al. | 2016-02-25 |
Heterocyclic Compound App 20160024049 - KOIKE; Tatsuki ;   et al. | 2016-01-28 |
1-arylcarbonyl-4-oxy-piperidine Compounds Useful For The Treatment Of Neurodegenerative Diseases App 20150376205 - KOIKE; Tatsuki ;   et al. | 2015-12-31 |
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases Grant 9,193,709 - Koike , et al. November 24, 2 | 2015-11-24 |
Heterocyclic Compound App 20150315209 - KOIKE; Tatsuki ;   et al. | 2015-11-05 |
Heterocyclic Compound App 20150266872 - Koike; Tatsuki ;   et al. | 2015-09-24 |
Fused triazoles for the treatment or prophylaxis of mild cognitive impairment Grant 8,901,309 - Koike , et al. December 2, 2 | 2014-12-02 |
Heterocyclic Compound And Use Thereof App 20140350260 - KOIKE; Tatsuki ;   et al. | 2014-11-27 |
Tricyclic compound and pharmaceutical use thereof Grant 8,895,591 - Uchikawa , et al. November 25, 2 | 2014-11-25 |
Heterocyclic compounds Grant 8,871,766 - Koike , et al. October 28, 2 | 2014-10-28 |
Heterocyclic compounds Grant 8,865,717 - Koike , et al. October 21, 2 | 2014-10-21 |
Heterocyclic compound and use thereof Grant 8,822,699 - Koike , et al. September 2, 2 | 2014-09-02 |
1-arylcarbonyl-4-oxy-piperidine Compounds Useful For The Treatment Of Neurodegenerative Diseases App 20140228373 - Koike; Tatsuki ;   et al. | 2014-08-14 |
Heterocyclic Compounds App 20140088146 - KOIKE; Tatsuki ;   et al. | 2014-03-27 |
Heterocyclic Compounds App 20140088118 - KOIKE; Tatsuki ;   et al. | 2014-03-27 |
Heterocyclic compounds Grant 8,648,079 - Koike , et al. February 11, 2 | 2014-02-11 |
Tricyclic Compound And Pharmaceutical Use Thereof App 20140011849 - UCHIKAWA; Osamu ;   et al. | 2014-01-09 |
Tricyclic compound and pharmaceutical use thereof Grant 8,552,037 - Uchikawa , et al. October 8, 2 | 2013-10-08 |
Fused Triazoles For The Treatment Or Prophylaxis Of Mild Cognitive Impairment App 20130178497 - Koike; Tatsuki ;   et al. | 2013-07-11 |
Heterocyclic Compounds App 20130090341 - KOIKE; Tatsuki ;   et al. | 2013-04-11 |
Tricyclic Compound And Pharmaceutical Use Thereof App 20130079374 - UCHIKAWA; Osamu ;   et al. | 2013-03-28 |
Tricyclic compound and pharmaceutical use thereof Grant 8,349,879 - Uchikawa , et al. January 8, 2 | 2013-01-08 |
Tricyclic compound and medical use thereof Grant 8,273,761 - Uchikawa , et al. September 25, 2 | 2012-09-25 |
Tricyclic compound and pharmaceutical use thereof Grant 8,247,429 - Uchikawa , et al. August 21, 2 | 2012-08-21 |
Tricyclic compound and pharmaceutical use thereof Grant 8,236,837 - Uchikawa , et al. August 7, 2 | 2012-08-07 |
Heterocyclic Compound And Use Thereof App 20120142672 - Koike; Tatsuki ;   et al. | 2012-06-07 |
Heterocyclic Compound And Use Thereof App 20120059030 - KOIKE; Tatsuki ;   et al. | 2012-03-08 |
Bicyclic compound and pharmaceutical use thereof Grant 8,110,585 - Koike , et al. February 7, 2 | 2012-02-07 |
Tricyclic compound and pharmaceutical use thereof Grant 8,030,337 - Uchikawa , et al. October 4, 2 | 2011-10-04 |
Tricyclic Compound And Pharmaceutical Use Thereof App 20110196003 - Uchikawa; Osamu ;   et al. | 2011-08-11 |
Tricyclic Compound And Pharmaceutical Use Thereof App 20110190361 - UCHIKAWA; Osamu ;   et al. | 2011-08-04 |
Bicyclic Compound And Pharmaceutical Use Thereof App 20100130538 - Koike; Tatsuki ;   et al. | 2010-05-27 |
Tricyclic Compound And Medical Use Thereof App 20100029707 - Uchikawa; Osamu ;   et al. | 2010-02-04 |
Tricyclic Compound And Pharmaceutical Use Thereof App 20100010038 - Uchikawa; Osamu ;   et al. | 2010-01-14 |
Tricyclic Compound And Pharmaceutical Use Thereof App 20090182023 - Uchikawa; Osamu ;   et al. | 2009-07-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.